Omeros OMER
NASDAQ OMER
$18.61 +0.14 (+0.76%)
At close: Oct 2, 2026 · 4:00 PM EDT

Omeros (OMER) Return on Capital Employed [ROCE] (2011 - 2026)

Updated

Omeros (OMER) posted Return on Capital Employed [ROCE] of -38.02% for Q2 2026, up 64.79 percentage points from -102.81% a year earlier and up 4.69 percentage points from the prior quarter.

Analysis

Omeros (OMER) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends

For FY2025, Omeros' Return on Capital Employed [ROCE] came in at -54.99%, up 12.29 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] shows a five-year change of +73.34 percentage points (FY2020 to FY2025).
  • In prior years, Omeros' Return on Capital Employed [ROCE] was -67.28% in FY2024 (-29.13 pp), -38.15% in FY2023 (+6.16 pp), -44.31% in FY2022 (+25.59 pp) and -69.90% in FY2021 (+58.43 pp).
  • The Q2 2026 figure stands as the highest quarterly Return on Capital Employed [ROCE] since Q1 2023.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has increased in each of the last three quarters, with an average year-over-year change of -8.90 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q3 2022, with a gain of 133.76 percentage points; the weakest was Q3 2021, with a drop of 80.31 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -42.70% (Q1 2026), -69.14% (Q4 2025) and -113.07% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Omeros 1.34 Bn 1.34 Bn 27.73 Mn -38.02%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -38.02%
Mar 31, 2026 -42.70%
Dec 31, 2025 -69.14%
Sep 30, 2025 -113.07%
Jun 30, 2025 -102.81%
Mar 31, 2025 -94.21%
Dec 31, 2024 -77.41%
Sep 30, 2024 -62.09%
Jun 30, 2024 -55.16%
Mar 31, 2024 -48.12%
Dec 31, 2023 -43.03%
Sep 30, 2023 -45.42%
Jun 30, 2023 -41.85%
Mar 31, 2023 -37.60%
Dec 31, 2022 -42.12%
Sep 30, 2022 -45.88%
Jun 30, 2022 -48.66%
Mar 31, 2022 -45.48%
Dec 31, 2021 -79.07%
Sep 30, 2021 -179.65%
API Access

Omeros Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=OMER&period=max&api_key=YOUR_API_KEY